
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Galectin-3 as a Next-Generation Biomarker for Detecting Early Stage of Various Diseases
Akira Hara, Masayuki Niwa, Kei Noguchi, et al.
Biomolecules (2020) Vol. 10, Iss. 3, pp. 389-389
Open Access | Times Cited: 176
Akira Hara, Masayuki Niwa, Kei Noguchi, et al.
Biomolecules (2020) Vol. 10, Iss. 3, pp. 389-389
Open Access | Times Cited: 176
Showing 1-25 of 176 citing articles:
Galectin-3 in Cardiovascular Diseases
Valeria Blanda, Umberto Marcello Bracale, Maria Donata Di Taranto, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 23, pp. 9232-9232
Open Access | Times Cited: 161
Valeria Blanda, Umberto Marcello Bracale, Maria Donata Di Taranto, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 23, pp. 9232-9232
Open Access | Times Cited: 161
Targeting galectin-3 in inflammatory and fibrotic diseases
Selena Bouffette, Iuliana Botez, Frédéric De Ceuninck
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 8, pp. 519-531
Open Access | Times Cited: 65
Selena Bouffette, Iuliana Botez, Frédéric De Ceuninck
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 8, pp. 519-531
Open Access | Times Cited: 65
PREDICTION OF INTERSTITIAL LUNG DISEASE PROGRESSION IN SYSTEMIC SCLEROSIS PATIENTS: A COHORT STUDY ANALYSIS
D. Khorolskii, ALESYA A. KLIMENKO, Е. С. Першина, et al.
The Bulletin of Contemporary Clinical Medicine (2024) Vol. 17, Iss. 2, pp. 79-84
Open Access | Times Cited: 18
D. Khorolskii, ALESYA A. KLIMENKO, Е. С. Першина, et al.
The Bulletin of Contemporary Clinical Medicine (2024) Vol. 17, Iss. 2, pp. 79-84
Open Access | Times Cited: 18
HIV- AND TUBERCULOSIS-ASSOCIATED PERICARDITIS
Е. А. Бородулина, K. Zhilinskaya, DANIIL A. TALAGAEV, et al.
The Bulletin of Contemporary Clinical Medicine (2024) Vol. 17, Iss. 2, pp. 91-97
Open Access | Times Cited: 18
Е. А. Бородулина, K. Zhilinskaya, DANIIL A. TALAGAEV, et al.
The Bulletin of Contemporary Clinical Medicine (2024) Vol. 17, Iss. 2, pp. 91-97
Open Access | Times Cited: 18
The therapeutic potential of galectin-3 inhibition in fibrotic disease
Robert J. Slack, Ross Mills, Alison C. MacKinnon
The International Journal of Biochemistry & Cell Biology (2020) Vol. 130, pp. 105881-105881
Open Access | Times Cited: 106
Robert J. Slack, Ross Mills, Alison C. MacKinnon
The International Journal of Biochemistry & Cell Biology (2020) Vol. 130, pp. 105881-105881
Open Access | Times Cited: 106
Hyperinflammation and Fibrosis in Severe COVID-19 Patients: Galectin-3, a Target Molecule to Consider
Juan García‐Revilla, Tomas Deierborg, José L. Venero, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 88
Juan García‐Revilla, Tomas Deierborg, José L. Venero, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 88
Cardiac biomarkers of heart failure in chronic kidney disease
Xiaorong Han, Shuai Zhang, Zhongbo Chen, et al.
Clinica Chimica Acta (2020) Vol. 510, pp. 298-310
Closed Access | Times Cited: 74
Xiaorong Han, Shuai Zhang, Zhongbo Chen, et al.
Clinica Chimica Acta (2020) Vol. 510, pp. 298-310
Closed Access | Times Cited: 74
Immunopathology of galectin-3: an increasingly promising target in COVID-19
John L. Caniglia, Swapna Asuthkar, Andrew J. Tsung, et al.
F1000Research (2020) Vol. 9, pp. 1078-1078
Open Access | Times Cited: 70
John L. Caniglia, Swapna Asuthkar, Andrew J. Tsung, et al.
F1000Research (2020) Vol. 9, pp. 1078-1078
Open Access | Times Cited: 70
Galectin-3 as a potential prognostic biomarker of severe COVID-19 in SARS-CoV-2 infected patients
Eduardo Cervantes-Álvarez, Nathaly Limon‐de la Rosa, Moisés Salgado-de la Mora, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 54
Eduardo Cervantes-Álvarez, Nathaly Limon‐de la Rosa, Moisés Salgado-de la Mora, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 54
Alzheimer’s disease and neuroinflammation: will new drugs in clinical trials pave the way to a multi-target therapy?
Daniela Melchiorri, Sara Merlo, Benjamin Micallef, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 26
Daniela Melchiorri, Sara Merlo, Benjamin Micallef, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 26
A novel pH/ROS dual responsive engineering hydrogels based on poly(tannic acid)-assisted surface deposition of nano-enzymes with efficient antibacterial and antioxidant activity for diabetic wound healing
Hongyu Li, Ying‐Ping Wang, Xiance Che, et al.
Chemical Engineering Journal (2024) Vol. 496, pp. 153370-153370
Closed Access | Times Cited: 10
Hongyu Li, Ying‐Ping Wang, Xiance Che, et al.
Chemical Engineering Journal (2024) Vol. 496, pp. 153370-153370
Closed Access | Times Cited: 10
Circulating Galectin-3 levels in women with polycystic ovary syndrome: A meta-analysis
Seyed Sobhan Bahreiny, Mohammad‐Navid Bastani, Mojtaba Aghaei, et al.
Taiwanese Journal of Obstetrics and Gynecology (2024) Vol. 63, Iss. 1, pp. 37-45
Open Access | Times Cited: 8
Seyed Sobhan Bahreiny, Mohammad‐Navid Bastani, Mojtaba Aghaei, et al.
Taiwanese Journal of Obstetrics and Gynecology (2024) Vol. 63, Iss. 1, pp. 37-45
Open Access | Times Cited: 8
Targeting Inflammation with Galectin-3 and PIIINP Modulation Among ST-Segment Elevation Acute Coronary Syndrome Patients Underwent Delayed Percutaneous Coronary Intervention
Saskia Dyah Handari, Saifur Rohman, Djanggan Sargowo, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 259-259
Open Access | Times Cited: 1
Saskia Dyah Handari, Saifur Rohman, Djanggan Sargowo, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 259-259
Open Access | Times Cited: 1
Galectin-3: Roles in Neurodevelopment, Neuroinflammation, and Behavior
Ivan Srejović, Dragica Selaković, Nemanja Jovičić, et al.
Biomolecules (2020) Vol. 10, Iss. 5, pp. 798-798
Open Access | Times Cited: 54
Ivan Srejović, Dragica Selaković, Nemanja Jovičić, et al.
Biomolecules (2020) Vol. 10, Iss. 5, pp. 798-798
Open Access | Times Cited: 54
Microneedle‐Based Technology: Toward Minimally Invasive Disease Diagnostics
Na Xu, Wenxin Xu, Manyue Zhang, et al.
Advanced Materials Technologies (2022) Vol. 7, Iss. 9
Closed Access | Times Cited: 34
Na Xu, Wenxin Xu, Manyue Zhang, et al.
Advanced Materials Technologies (2022) Vol. 7, Iss. 9
Closed Access | Times Cited: 34
Galectin-3 is elevated in CSF and is associated with Aβ deposits and tau aggregates in brain tissue in Alzheimer’s disease
Antonio Boza‐Serrano, Agathe Vrillon, Karolina Minta, et al.
Acta Neuropathologica (2022) Vol. 144, Iss. 5, pp. 843-859
Open Access | Times Cited: 32
Antonio Boza‐Serrano, Agathe Vrillon, Karolina Minta, et al.
Acta Neuropathologica (2022) Vol. 144, Iss. 5, pp. 843-859
Open Access | Times Cited: 32
A Biomolecular Toolbox for Precision Nanomotors
Joel Yong, Albert S. Mellick, John M. Whitelock, et al.
Advanced Materials (2022), pp. 2205746-2205746
Open Access | Times Cited: 32
Joel Yong, Albert S. Mellick, John M. Whitelock, et al.
Advanced Materials (2022), pp. 2205746-2205746
Open Access | Times Cited: 32
Implicative role of epidermal growth factor receptor and its associated signaling partners in the pathogenesis of Alzheimer’s disease
Pavan K. Jayaswamy, M. Vijaykrishnaraj, Prakash Patil, et al.
Ageing Research Reviews (2022) Vol. 83, pp. 101791-101791
Closed Access | Times Cited: 32
Pavan K. Jayaswamy, M. Vijaykrishnaraj, Prakash Patil, et al.
Ageing Research Reviews (2022) Vol. 83, pp. 101791-101791
Closed Access | Times Cited: 32
Sexual Dimorphism in Cardiovascular Biomarkers: Clinical and Research Implications
Emily S. Lau, Aleksandra Binek, Sarah J. Parker, et al.
Circulation Research (2022) Vol. 130, Iss. 4, pp. 578-592
Open Access | Times Cited: 29
Emily S. Lau, Aleksandra Binek, Sarah J. Parker, et al.
Circulation Research (2022) Vol. 130, Iss. 4, pp. 578-592
Open Access | Times Cited: 29
Galectin-3: therapeutic targeting in liver disease
Alison C. MacKinnon, Dimitar Tonev, Brian Jacoby, et al.
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 9, pp. 779-791
Open Access | Times Cited: 21
Alison C. MacKinnon, Dimitar Tonev, Brian Jacoby, et al.
Expert Opinion on Therapeutic Targets (2023) Vol. 27, Iss. 9, pp. 779-791
Open Access | Times Cited: 21
Correlation Analysis of Galectin-3 Serum Level in Obesity with and without Obesity
Nurjannah Nurjannah, Nurahmi Nurahmi, Liong Boy Kurniawan
INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY (2023) Vol. 29, Iss. 3, pp. 216-219
Open Access | Times Cited: 19
Nurjannah Nurjannah, Nurahmi Nurahmi, Liong Boy Kurniawan
INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY (2023) Vol. 29, Iss. 3, pp. 216-219
Open Access | Times Cited: 19
Cardiac Biomarkers and Their Role in Identifying Increased Risk of Cardiovascular Complications in COVID-19 Patients
Nagendra Yaluri, Alena Stančáková Yaluri, Pavol Žeňuch, et al.
Diagnostics (2023) Vol. 13, Iss. 15, pp. 2508-2508
Open Access | Times Cited: 18
Nagendra Yaluri, Alena Stančáková Yaluri, Pavol Žeňuch, et al.
Diagnostics (2023) Vol. 13, Iss. 15, pp. 2508-2508
Open Access | Times Cited: 18
Novel Biomarkers in Early Detection of Heart Failure: A Narrative Review
Maryam Kayani, Neha Fatima, Pooja Chowdary Yarra, et al.
Cureus (2024)
Open Access | Times Cited: 7
Maryam Kayani, Neha Fatima, Pooja Chowdary Yarra, et al.
Cureus (2024)
Open Access | Times Cited: 7
Immunopathology of galectin-3: an increasingly promising target in COVID-19
John L. Caniglia, Swapna Asuthkar, Andrew J. Tsung, et al.
F1000Research (2020) Vol. 9, pp. 1078-1078
Open Access | Times Cited: 48
John L. Caniglia, Swapna Asuthkar, Andrew J. Tsung, et al.
F1000Research (2020) Vol. 9, pp. 1078-1078
Open Access | Times Cited: 48
Galectin-3 in Kidney Diseases: From an Old Protein to a New Therapeutic Target
Louis Boutin, François Dépret, Étienne Gayat, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3124-3124
Open Access | Times Cited: 27
Louis Boutin, François Dépret, Étienne Gayat, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3124-3124
Open Access | Times Cited: 27